Judge may block $69B CVS-Aetna deal

Though regulators have signed off on the $69 billion merger between CVS Health and Aetna, a U.S. District Court judge may block the deal, The New York Post reported. The action could complicate the transaction, delaying it for months, despite the fact the two companies have already started integrating and have closed the deal.

Judge Richard Leon signaled he was considering blocking the deal over the last few weeks, stating regulators had given the merger a “rubber stamp” approval.

The next hearing is scheduled for Tuesday, and Leon could very well block the deal, the report stated.

The Department of Justice approved the deal in November on the contingency that Aetna sell its Medicare Part D prescription drug business. WellCare Health Plans agreed to purchase the business in October.

If Judge Leon decides to call an injunction next week, he could then schedule more hearings to determine if the sale of Aetna’s Part D business addresses the concerns of the government. Namely, he could call the American Medical Association as a witness, The Post predicted. The association previously voiced its concerns over the transaction’s impact on competition and the potential negative impact on patients.

“CVS Health and Aetna are one company, and we look forward to sharing with Judge Leon how we’re already helping patients and members on their path to better health,” a CVS Health spokesperson told The New York Post.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup